Rannio, T., Asikainen, J., Hannonen, P., Yli-Kerttula, T., Ekman, P., Pirilä, L., . . . Kautiainen, H. (2017). Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: Results from the FIN-ERA cohort. Scandinavian Journal of Rheumatology, 46(6), 425. https://doi.org/10.1080/03009742.2016.1266029
Chicago Style (17th ed.) CitationRannio, T., et al. "Three Out of Four Disease-modifying Anti-rheumatic Drug-naïve Rheumatoid Arthritis Patients Meet 28-joint Disease Activity Score Remission at 12 months: Results from the FIN-ERA Cohort." Scandinavian Journal of Rheumatology 46, no. 6 (2017): 425. https://doi.org/10.1080/03009742.2016.1266029.
MLA (9th ed.) CitationRannio, T., et al. "Three Out of Four Disease-modifying Anti-rheumatic Drug-naïve Rheumatoid Arthritis Patients Meet 28-joint Disease Activity Score Remission at 12 months: Results from the FIN-ERA Cohort." Scandinavian Journal of Rheumatology, vol. 46, no. 6, 2017, p. 425, https://doi.org/10.1080/03009742.2016.1266029.